Devonian Health Group Statistics

Total Valuation

Devonian Health Group has a market cap or net worth of CAD 22.97 million. The enterprise value is 12.79 million.

Market Cap	22.97M
Enterprise Value	12.79M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Devonian Health Group has 148.22 million shares outstanding. The number of shares has increased by 6.04% in one year.

Current Share Class	n/a
Shares Outstanding	148.22M
Shares Change (YoY)	+6.04%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.83%
Owned by Institutions (%)	n/a
Float	127.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.02
PB Ratio	1.58
P/TBV Ratio	4.86
P/FCF Ratio	2.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 112.61, with an EV/FCF ratio of 1.45.

EV / Earnings	-14.79
EV / Sales	0.57
EV / EBITDA	112.61
EV / EBIT	n/a
EV / FCF	1.45

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.16.

Current Ratio	1.13
Quick Ratio	1.11
Debt / Equity	0.16
Debt / EBITDA	20.00
Debt / FCF	0.26
Interest Coverage	-1.55

Financial Efficiency

Return on equity (ROE) is -6.06% and return on invested capital (ROIC) is -1.97%.

Return on Equity (ROE)	-6.06%
Return on Assets (ROA)	-1.29%
Return on Capital (ROIC)	-1.97%
Revenue Per Employee	3.20M
Profits Per Employee	-123,534
Employee Count	8
Asset Turnover	0.86
Inventory Turnover	150.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.73% in the last 52 weeks. The beta is 1.42, so Devonian Health Group's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-29.73%
50-Day Moving Average	0.17
200-Day Moving Average	0.17
Relative Strength Index (RSI)	44.92
Average Volume (20 Days)	4,505

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Devonian Health Group had revenue of CAD 22.39 million and -864,740 in losses. Loss per share was -0.01.

Revenue	22.39M
Gross Profit	7.18M
Operating Income	-541,840
Pretax Income	-864,740
Net Income	-864,740
EBITDA	77,833
EBIT	-541,840
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 12.45 million in cash and 2.27 million in debt, giving a net cash position of 10.18 million or 0.07 per share.

Cash & Cash Equivalents	12.45M
Total Debt	2.27M
Net Cash	10.18M
Net Cash Per Share	0.07
Equity (Book Value)	14.50M
Book Value Per Share	0.10
Working Capital	2.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.86 million and capital expenditures -21,597, giving a free cash flow of 8.84 million.

Operating Cash Flow	8.86M
Capital Expenditures	-21,597
Free Cash Flow	8.84M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 32.06%, with operating and profit margins of -2.42% and -3.86%.

Gross Margin	32.06%
Operating Margin	-2.42%
Pretax Margin	-3.86%
Profit Margin	-3.86%
EBITDA Margin	0.35%
EBIT Margin	-2.42%
FCF Margin	39.48%

Dividends & Yields

Devonian Health Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.04%
Shareholder Yield	-6.04%
Earnings Yield	-3.78%
FCF Yield	38.48%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Devonian Health Group has an Altman Z-Score of 0.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.38
Piotroski F-Score	n/a